Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemaseproducing isolates of Klebsiella pneumoniae in South Africa

South African Medical Journal

Volumn 105, Issue 12, 2015, Pages 1030-1035

  Jacobson, Rachael Kiera ^a,b   Manesen, Mohnamed Riyadh ^c,d,e   Moodley, Clinton ^a,b   Smith, Mariette ^a   Williams, Seymour ^c,e   Nicol, Mark ^a,b   Bamford, Colleen ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antibiotic resistance; Epidemiology; Klebsiella

Indexed keywords

AMPICILLIN; CARBAPENEMASE; CEFOTAXIME; CEFOXITIN; CEFUROXIME; COLISTIN; ERTAPENEM; IMIPENEM; MEROPENEM; MOXICILLIN PLUS CLAVULANIC ACID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLAOXA 181 CARBAPENEMASE GENE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLINICAL ARTICLE; EPIDEMIOLOGICAL MONITORING; FECES ANALYSIS; FEMALE; GENE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; SOUTH AFRICA; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIC; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84948757315     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.2015.v105i12.9926     Document Type: Article

References (31)

1. Fishman N. Antimicrobial stewardship. Am J Med 2006; 119(6A): S53-S61. [http://dx. doi. org/10. 1016/jamjmed. 2006. 04. 003].
2. Goff D. Antimicrobial stewardship: Bridging the gap between quality care and cost. Curr Opin Infect Dis 2011; 24(Suppl 1): S11-S20. [http://dx. doi. org/10. 1097/01. qco. 0000393484. 17894. 05].
3. Hall BG, Barlow M. Revised Ambler classification of beta-lactamases. J Antimicrob Chemother 2005; 55(6): 1050-1051. [http://dx. doi. org/10. 1093/jac/dkil30].
4. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: The phantom menace. J Antimicrob Chemother 2012; 67(7): 1597-1606. [http://dx. doi. org/10. 1093/dks121].
5. Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48(1): 15-22. [http://dx. doi. org/10. 1128/AAC. 48. 1. 15-22. 2004].
6. Brink AJ, Coetzee J, Corcoran C, et al. Emergence of OXA-48 and OXA-181 carbapenemases amongst Enterobacteriaceae in South Africa, and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastro-intestinal tract. J Clin Microbiol 2013; 51(1): 369-372. [http://dx. doi. org/10. 1128/JCM. 02234-12].
7. Potron A, Nordmann P, Lafeuille E, et al. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55(10): 4896-4899. [http://dx. doi. org/10. 1128/AAC. 00481-11].
8. Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob Chemother 2012; 67(7): 1660-1665. [http://dx. doi. org/10. 1093/jac/dks124].
9. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemaseproducing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012; 18(5): E144-148. [http://dx. doi. org/10. 1111/j. 1469-0691. 2012. 03796.
10. Kalpoe JS, Al Naiemi N, Poirel L, Nordmann P. Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. J Med Microbiol 2011; 60(5): 677-678. [http://dx. doi. org/10. 1099/jmm. 0. 028308-0].
11. Balm MND, Ngan G, Jureen R, et al. OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect Dis 2013; 13: 58. [http://dx. doi. org/10. 1186/1471-2334-13-58].
12. Williamson DA, Heffernan H, Sidjabat H, et al. Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand. J Antimicrob Chemother 2011; 66(12): 2888-2890. [http://dx. doi. org/10. 1093/jac/dkr396].
13. Manenzhe R, Zar H, Nicol M, Kaba M. The spread of carbapenem producing bacteria: A systematic review. J Antimicrob Chemother 2015; 70(1): 23-40. [http://dx. doi. org/10. 1093/jac/dku356].
14. Madau M, Jacobson R, Minenza N, et al. Outbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a South African academic hospital. PLoS One 2013; 8(3): E55985. [http://dx. doi. org/10. 1371/journal. pone. 0055985].
15. Marchaim D, Chopra T, Pogue JM, et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. J Antimicrob Chemother 2011; 55(2): 593-599. [http://dx. doi. org/10. 1128/AAC. 01020-10].
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement, M100-S22S21. Wayne, PA: CLSI, 2012.
17. Segal H, Elisha BG. Resistance to beta-lactams, and reduced susceptibility to carbapenems, in clinical isolates of Klebsiella pneumoniae due to interplay between CTX-M-15 and altered outer membrane permeability. South African Journal of Epidemiology and Infection 2006; 21(2): 41-44.
18. Jacobson RK, Minenza N, Nicol M, Bamford C. VIM-2 metallo-beta-lactamase producing Pseudomonas aeruginosa causing an outbreak in South Africa. J Antimicrob Chemother 2012; 67(7): 1797-1798. [http://dx. doi. org/10. 1093/jac/dks100].
19. Poirel L, Revathi G, Bernabeau S, Nordman P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 2011; 55(2): 934-936. [http://dx. doi. org/10. 1128/AAC. 01247-10].
20. Manesen R, Bamford C, Smith M, et al. Outbreak of carbapenem-resistant Klebsiella species in an academic hospital, Western Cape, May 2012. National Institute for Communicable Diseases Surveillance Bulletin 2012; 10(4): 82-86.
21. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45(4): 1151-1161. [http://dx. doi. org/10. 1128/AAC. 45. 4].
22. Poirel L, Magalhaes M, Lopes M, Nordmann P. Molecular analysis of metallo-β lactamase gene blaSPM-1-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother 2004; 48(4): 1406-1409. [http://dx. doi. org/10. 1128/AAC. 48. 4. 1406-1409. 2004].
23. Perilli M, Dell'Amico E, Segatore B, et al. Molecular characterization of extended spectrum betalactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002; 40(2): 611-614. [http://dx. doi. org/10. 1128/JCM. 40. 2. 611-614. 2002].
24. Canica MM, Lu CY, Krishnamoorthy R, Paul GC. Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli. J Mol Evol 1997; 44(1): 57-65.
25. Nelson EC, Segal H, Elisha BG. Outer membrane protein alterations and blaTEM-1 variants: Their role in β-lactam resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 2003; 52(6): 899-903. [http://dx. doi. org/10. 1093/jac/dkg486].
26. Poirel L, Decousser J, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene. Antimicrob Agents Chemother 2003; 47(9): 2938-2945. [http://dx. doi. org/10. 1128/AAC. 47. 9. 2938-2945. 2003].
27. Pulse Net USA. One-day (24-28 h) standardized laboratory protocol for molecular subtyping of Escherichia coli O157: H7, Salmonellaserotypes, Shigella sonnei, and Shigella flexneri by pulsed field gel electrophoresis (PFGE) 2009; (10): 1-16. http://www. pulsenetinternational. org/assets/PulseNet/uploads/pfge/PNL05_Ec-Sal-ShigPFGEprotocol. pdf (accessed 6 November 2015).
28. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995; 33(9): 2233-2239.
29. Diancourt L, Passet V, Verhoef J, et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43(8): 4178-4182. [http://dx. doi. org/10. 128/JCM. 43. 8. 4178-4182. 2005].
30. Institut Pasteur. Klebsiella pneumoniae MLST database. http://www. pasteur. fr/mlst (accessed 24 January 2015).
31. Girlich D, Poirel L, Nordmann P. Value of the modified Hodge test for the detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2012; 50(2): 477-479. [http://dx. doi. org/10. 1128/JCM. 05247-11].